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Abstract
Background: Structural and functional changes of the hippocampus are correlated with psychiatric disorders and
cognitive dysfunctions. Genetic deletion of heparin-binding epidermal growth factor-like growth factor (HB-EGF),
which is predominantly expressed in cortex and hippocampus, also causes similar psychiatric and cognitive
dysfunctions, accompanying down-regulated NMDA receptor signaling. However, little is known of such dysfunctions
in hippocampus-specific Hbegf cKO mice.
Results: We successfully developed hippocampus-specific cKO mice by crossbreeding floxed Hbegf and Gng7-Cre
knock-in mice, as Gng7 promoter-driven Cre is highly expressed in hippocampal neurons as well as striatal medium
spiny neurons. In mice lacking hippocampus Hbegf gene, there was a decreased neurogenesis in the subgranular zone
(SGZ) of the dentate gyrus as well as down-regulation of PSD-95/NMDA-receptor-NR1/NR2B subunits and related
NMDA receptor signaling. Psychiatric, social-behavioral and cognitive abnormalities were also observed in hippocampal
cKO mice. Interestingly, D-cycloserine and nefiracetam, positive allosteric modulators (PAMs) of NMDA receptor
reversed the apparent reduction in NMDA receptor signaling and most behavioral abnormalities. Furthermore,
decreased SGZ neurogenesis in hippocampal cKO mice was reversed by nefiracetam.
Conclusions: The present study demonstrates that PAMs of NMDA receptor have pharmacotherapeutic potentials to
reverse down-regulated NMDA receptor signaling, neuro-socio-cognitive abnormalities and decreased neurogenesis in
hippocampal cKO mice.
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Background
According to the National Comorbidity Survey Replica-
tion, more than one-quarter of adult Americans would
be diagnosed with DSM-IV mental disorders based on a
fully structured diagnostic interview [1]. Structural and
functional changes of the hippocampus are correlated
with neuropsychiatric disorders, including major de-
pression, which is associated with a reduced hippo-
campal volume and consequent functional deficits [2,
3]. Hippocampal dysfunction is also closely associated
with cognitive dysfunction, as seen in schizophrenia,
attention-deficit hyperactivity disorder (ADHD) and
Alzheimer’s disease [4–6].
Heparin-binding EGF-like growth factor (HB-EGF) is an
endogenous ligand for EGF receptors, as described for
ErbB1 and ErbB4 [7, 8]. Moreover, ErbB4 displays cross
talk with postsynaptic density-95 (PSD-95) and NMDA
receptor signaling, which are closely related to behavioral
abnormalities [9, 10]. Accumulating evidence has sug-
gested that tight coupling of the ErbB4–PSD-95–NMDA
receptor complex may underlie the pathophysiological
molecular signature of psychiatric and cognitive disorders
[11–13]. Conditional knockout (cKO) mice lacking Hbegf
in the ventral forebrain showed some cognitive and
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neuropsychiatric abnormalities [12, 13]. There are many
reports of cKO mice showing psychological disorders and
most of these cKO mice are deficient in specific molecules
in both the cerebral cortex and hippocampus. However,
very few descriptions of psychological and learning disor-
ders in hippocampus-specific Hbegf cKO mice exist. The
present study focused on behavioral phenotypes and
therapeutic specificity in mice with a hippocampal defi-
ciency of the Hbegf gene, as the hippocampus is known to
be closely related to depression [2, 3], psychiatric disorders
[4], cognition [5, 6] and neurogenesis [14–16]. Therefore,
we developed hippocampus-specific cKO mice by cross-
breeding floxed Hbegf [17] and Gng7-Cre knock-in mice
[18], as Gng7 promoter-driven Cre is highly expressed in
hippocampal neurons as well as striatal medium spiny neu-
rons, while Hbegf is highly expressed in cerebral cortex and
hippocampal neurons [19, 20]. The resultant hippocampus-
specific cKO mice retained the neuropsychiatric disorders
as well as decreased learning potential, and also showed
down-regulation of NMDA receptor signaling molecules.
Additionally, these mice showed marked defects in neuro-
genesis. In the present study, we characterized the patho-
physiological features of these hippocampus-specific Hbegf
cKO mice in relation to ADHD and obsessive-compulsive
disorder (OCD), and propose therapeutic avenues for inhi-
biting these features.
Results
Generation of hippocampal Hbegf knockout mice
Hippocampus is the epicenter of learning and episodic
memory [21], changes in the ultrastructure [22] and
biochemical circuitry [23] have been implicated in
neuropsychiatric disorders. Since development and
maintenance of hippocampal structure and neuronal
connectivity is tightly regulated by several growth factors
[24], including HB-EGF [12] whose ablation in hippo-
campus has been linked with neuropsychiatric episodes
in mice [13]. In this study, hippocampal neuron-specific
Hbegf knockout (KO) mice was generated using floxed
Hbegf knock-in mice [17, 25] and transgenic mice that
express Cre recombinase under the control of a G pro-
tein γ subunit 7 gene (Gng7) promoter (Fig. 1a) [18].
These mice were crossbred and the resulting Gng7 wt/cre;
Hbegf wt/flox mice were backcrossed with Hbegf flox/flox
mice to generate Gng7 wt/cre; Hbegf flox/flox mice. The
genotypes of Gng7 wt/cre; Hbegf flox/flox mice were deter-
mined by PCR as described previously [26]. Gng7/Gng7-
Cre bands (495 bp/570 bp) and floxed Hbegf bands
(800 bp) were determined in the Gng7 wt/cre and Hbegf
flox/flox mice DNA samples (Fig. 1b) respectively.
In order to confirm the successful hippocampal dele-
tion of Hbegf using cre-lox system, LacZ staining was
conducted using 30 μm brain sections from male Gng7
wt/cre; Hbegf flox/flox mice. In the adult hippocampus,
LacZ-positive cells (blue) were mainly observed in hip-
pocampal DG and CA3–CA1 layers. However, a number
of cells in the cerebellar granule cell layer were also
positive (Fig. 1c, d). qPCR analysis also revealed that
Hbegf cKO mice showed a significant reduction of
hippocampal (Hip) Hbegf mRNA, but there was no
significant decrease in olfactory bulb (Olf ), striatum
(Str), cortex (Cor) or cerebellum (Cere), compared with
Fig. 1 Generation and determination of restricted HB-EGF deletion in Hbegf cKO mice. a Genomic structure and the design of the Hbegf cKO
mice. b Genotyping of Hbegf cKO mice by PCR. c Regional specificity of Hbegf deletion. LacZ staining of Hbegf cKO mice brain section shows
specific expression of lacZ in parts of the brain including the hippocampal CA1, CA3 and dentate gyrus (DG) regions, and the cerebellar granule
cell layer. d Brain coronal sections with LacZ staining in Hbegf cKO mice. LacZ positive cells are indicated by arrow heads. e Quantitative analysis
of Hbegf mRNA expression in brain regions. n = 4 (Control), n = 4 (cKO). Values are the means ± s.e.m. Olf, olfactory bulb; Str, striatum; Cor, cortex;
Hip, hippocampus; Cere, cerebellum
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control mice (Fig. 1e). Data were analyzed by Student’s t
test (Olf: Cont: 100.00 ± 13.23 %; cKO: 75.78 ± 6.73 %; t =
1.761 df = 6, p = 0.1286, Str: Cont: 100.00 ± 22.96 %; cKO:
92.82 ± 14.93 %; t = 0.4295 df = 6, p = 0.6826, Cor: Cont:
100.00 ± 24.32 %; cKO: 70.34 ± 6.26 %; t = 1.413 df = 6, p =
0.6826, Hip: Cont: 100.00 ± 26.59 %; cKO: 16.13 ± 1.37 %;
t = 3.492 df = 6, p = 0.013, Cere: Cont: 100.00 ± 10.93 %;
cKO: 16.13 ± 10.53 %; t = 0.1985 df = 6, p = 0.849). No
LacZ-signals were observed in male Gng7-Cre knock-in
mice or floxed Hbegf knock-in mice (Additional file 1:
Figure S1). Male hippocampal Hbegf cKO (Gng7 wt/cre;
Hbegf flox/flox) mice showed no remarkable differences in
body weight (Cont: 29.24 ± 0.4610 g, n = 9; cKO:
28.77 ± 0.4123 g, n = 10; Student’s t test: t = 0.7696,
df = 17, p = 0.4521), body temperature (Cont: 36.80 ±
0.1443 °C, n = 9; cKO: 36.64 ± 0.1310 °C, n = 10; Stu-
dent’s t test: t = 0.8229, df = 17, p = 0.4219), wire hanging
(Cont: 173.4 ± 4.811 s, n = 9; cKO: 171.8 ± 5.629 s, n = 10;
Student’s t test: t = 0.2195, df = 17, p = 0.8288), thermal
nociceptive threshold (Cont: 8.600 ± 0.6978 s, n = 9; cKO:
8.660 ± 0.7559 s, n = 10; Student’s t test: t = 0.05790,
df = 17, p = 0.9545), and electrical stimulation-induced
paw withdrawal latency (Aβ-fiber: Cont: 382.2 ± 24.25,
n = 9; cKO: 381.0 ± 14.87, n = 10; Student’s t test: t =
0.04396, df = 17, p = 0.9654, Aδ-fiber: Cont: 134.4 ±
12.71, n = 9; cKO: 142.5 ± 9.347, n = 10; Student’s t
test: t = 0.5179, df = 17, p = 0.6112, and C-fiber: Cont:
86.33 ± 6.410, n = 9; cKO: 74.70 ± 5.391, n = 10; Stu-
dent’s t test: t = 1.398, df = 17, p = 0.18), compared
with control mice (Fig. 2a–e). Furthermore, the cKO
mice showed no significant motor dysfunction in
terms of coordination (rotarod training: two-way re-
peated measures ANOVA, genotype effect, 1–12 trials,
F(1,17) = 0.057, p = 0.814, test period: 10 rpm: Cont:
60.00 ± 0.0, n = 9; cKO: 59.87 ± 0.1333, n = 10; Stu-
dent’s t test: t = 0.9459, df = 17, p = 0.3574, 20 rpm:
Cont: 56.33 ± 1.954, n = 9; cKO: 54.43 ± 3.220, n = 10;
Student’s t test: t = 0.4906, df = 17, p = 0.63, 30 rpm:
Cont: 28.11 ± 4.713, n = 9; cKO: 29.77 ± 4.427, n = 10;
Student’s t test: t = 0.2562, df = 17, p = 0.8009, and
40 rpm: Cont: 14.04 ± 3.193, n = 9; cKO: 12.17 ± 3.589,
n = 10; Student’s t test: t = 0.3857, df = 17, p = 0.7045),
balance (stationary horizontal thin-rod test, two-way
repeated measures ANOVA, genotype effect, 1–12
Fig. 2 Characteristics of general health, sensory and motor function in Hbegf cKO mice. No significant changes in body weight: a, body temperature:
b, neuromuscular strength in the wire hang test: c, thermal-nociceptive threshold using the thermal stimulator: d, or the electrical threshold of
peripheral nerve (Aβ, Aδ, C-fiber) using a Neurometer CPT system: e were observed. No significant change in the latency to fall in the rotarod training:
f, and test period using different speeds of 10, 20, 30, and 40 rpm: g, h, No significant change in the stationary horizontal thin-rod test. No significant
change in the accelerating rotarod test in repetitive trials: i, and with differential speeds: j. During the training period, each mouse was placed on the
rotarod revolving at a constant speed (4.5 rpm) and then accelerated to 45 rpm. Mice were trained for 3 consecutive days, receiving four trials per day
with a 1 h inter-trial interval: (i). During the test period on day 4, mice were tested in seven consecutive 60 s trials at constant speeds of 5, 12, 18, 25,
31, 40 and 45 rpm. The mean latency to fall from the rotarod (for the three trials at each speed level) was recorded: (j). n = 7 (Control), n = 7 (cKO). All
results are presented as means ± s.e.m
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trials, F(1,17) = 0.883, p = 0.360) and learning (accelerat-
ing rotarod training: two-way repeated measures
ANOVA, genotype effect, 1–12 trials, F(1,12) = 0.074, p =
0.790, test period: 5 rpm: Cont: 60.00 ± 0.0, n = 7; cKO:
60.00 ± 0.0, n = 7, 12 rpm: Cont: 60.00 ± 0.0, n = 7; cKO:
59.57 ± 0.4286, n = 7; Student’s t test: t = 1.000, df = 12,
p = 0.337, 18 rpm: Cont: 57.29 ± 1.761, n = 7; cKO:
59.05 ± 0.6801, n = 7; Student’s t test: t = 0.9331, df =
12, p = 0.3692, 25 rpm: Cont: 46.67 ± 4.813, n = 7;
cKO: 47.81 ± 2.796, n = 7; Student’s t test: t = 0.2053,
df = 12, p = 0.8408, 31 rpm: Cont: 42.48 ± 4.251, n = 7;
cKO: 36.62 ± 3.368, n = 7; Student’s t test: t = 1.080, df =
12, p = 0.3014, 40 rpm: Cont: 28.62 ± 4.132, n = 7; cKO:
27.90 ± 2.907, n = 7; Student’s t test: t = 0.1414, df = 12,
p = 0.8899, and 45 rpm: Cont: 20.33 ± 3.895, n = 7;
cKO: 17.33 ± 1.471, n = 7; Student’s t test: t = 0.7206,
df = 12, p = 0.485), as shown in Fig. 2f–j.
Reduced NMDA receptor subunit expression and altered
LTP in hippocampal Hbegf knockout mice
ErbB4, a bonafide receptor of HB-EGF is known to
associate with postsynaptic density-95 (PSD-95) [27],
PSD-95 in turn has been identified as component of the
scaffold complex involved in NMDA receptor aggrega-
tion in the CNS [28] via biophysical interaction with the
C-terminus of the receptor. Accumulating evidence sug-
gest that de-coupling ErbB4–PSD-95–NMDA receptor
interaction due to mutation or/and reduced expression
of any of the member component may represent a key
molecular signature of psychiatric episodes, cognitive
disorders [29] and altered long-term potentiation (LTP).
Western blot analysis performed on male Hbegf cKO
mice showed significantly reduced hippocampal NR1/
NR2B-NMDA receptor subunits and PSD-95, but not
the NR2A subunit, compared with control mice (Fig. 3a).
Student’s t test was used to compare the differences be-
tween protein levels in control and cKO mice (NR1: Cont:
100.0 ± 9.045 %, n = 8; cKO: 70.66 ± 3.499 %, n = 8; t =
3.026, df = 14, p = 0.0091, PSD-95: Cont: 100.0 ± 10.43 %,
n = 8; cKO: 63.30 ± 11.71 %, n = 8; t = 2.340, df = 14, p =
0.0346, NR2A: Cont: 100.0 ± 6.226 %, n = 8; cKO: 92.55 ±
21.16 %, n = 8; t = 0.3376, df = 14, p = 0.7407, NR2B: Cont:
100.0 ± 17.17 %, n = 8; cKO: 53.81 ± 10.92 %, n = 8; t =
2.270, df = 14, p = 0.0395). To investigate resulting changes
in LTP in Hbegf cKO mice, we performed electrophysi-
ology experiments using acutely prepared hippocampal
slices from male control and cKO mice.
Slices were placed over a multi-electrode array; a bipo-
lar stimulation electrode was positioned on the Schaffer
collaterals region, and extracellular recordings using a
multi-electrode array (MED64, Alpha Med Sciences,
Japan, Fig. 3b). Each field excitatory post-synaptic poten-
tial (fEPSP) in the Schaffer collateral/CA1 hippocampal
pathway was adjusted to evoke a response with an
amplitude of 30–40 % of the maximum population spike
amplitude induced by bipolar constant current pulses
(3–50 μA, 0.1 ms), through a 0.1–10 kHz bandpass filter.
Each stimulation sequence consisted of a random im-
pulse train of 200 pulses applied every 30 s. After allow-
ing a stable baseline of 10 min, three theta burst stimuli
were given to the slice, with each consisting of a ten-
burst train of four pulses (100 Hz) with 200 ms inter-
train intervals. The fEPSPs 30 min after the theta burst
stimuli were markedly enhanced in slices from male
control mice, but the enhancement was significantly de-
creased in slices from male cKO mice after 30 min
(Fig. 3c, d). Repeated measures two-way ANOVA was
used to compare the differences between amplitude
levels in control and cKO mice (genotype effect, 0–30
min, F(1,14) = 13.23, p = 0.003).
Interestingly, some studies have demonstrated that
LTP enhances neurogenesis in the adult dentate gyrus
[30] and that recombinant HB-EGF administration in-
creased the number of BrdU-positive cells in the dentate
gyrus (DG) of adult mice [14]. Here, BrdU labeling of
newborn neurons in the subgranular zone (SGZ) of the
dentate gyrus, subventricular zone (SVZ) of the lateral
ventricle, rostral migratory stream (RMS), and the olfac-
tory bulb (OLF) was performed (Fig. 4a). As shown in
Fig. 4b, male Hbegf cKO mice showed significant de-
crease in the number of BrdU positive cells in the SGZ
(Cont: 2477 ± 166.7, cKO: 1148 ± 68.31, p = 0.0003), but
not in other regions, compared with control mice (SVZ:
Cont: 8693 ± 173.8; cKO: 8348 ± 179.9; t = 1.365, df = 7,
p = 0.2145, OLF: Cont: 7122 ± 166.9; cKO: 7384 ± 320.7;
t = 0.7733, df = 7, p = 0.4646, RMS: Cont: 6470 ± 315.0;
cKO: 6836 ± 243.4; t = 0.8783, df = 7, p = 0.4089). n = 5
(Control), n = 4 (cKO). Given that some new neurons
were formed in the Hbegf cKO mice, next, we sought to
establish the morphological effects of Hbegf ablation on
the developing neurons. When immature neurons were
stained using an anti- doublecortin (DCX) antibody,
DCX-positive cells were found in the SGZ of the DG
(Fig. 4c). Most DCX-positive cells were located in the
SGZ and the inner granule cell layer (GCL) of the DG
(Layer 2) in male control mice. In contrast, male cKO
mice showed mis-positioning of DCX-positive cells
(Fig. 4d), which were found in the middle to outer layer
of the GCL instead (layers #3–5), but there was no sig-
nificant difference in the total number of DCX positive
cells in DG (Cont: 374.8 ± 44.99; cKO: 451.9 ± 21.37;
Student’s t test: t = 1.548, df = 6, p = 0.1725, Fig. 4e).
Among sub regions of DG, there were significant in-
crease in the number of positive cells in mis-positioned
areas such as granular cell layer/GCL and molecular cell
layer/MOL (#3-5), but not in hilus layer/HIL (#1) or
subgranular zone/SGZ (#2) (layer 1: Cont: 67.25 ± 9.259;
cKO: 84.13 ± 4.598; Student’s t test: t = 1.632, df = 6, p =
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0.1537, layer 2: Cont: 256.5 ± 26.84; cKO: 246.8 ± 20.85;
Student’s t test: t = 0.287, df = 6, p = 0.7838, layer 3:
Cont: 25.00 ± 6.151; cKO: 50.75 ± 6.142; Student’s t test:
t = 2.962, df = 6, p = 0.0252, layer 4: Cont: 14.50 ± 4.173;
cKO: 33.75 ± 2.665; Student’s t test: t = 3.887, df = 6, p =
0.0081, layer 5: Cont: 11.50 ± 4.444; cKO: 36.50 ± 1.242;
Student’s t test: t = 5.418, df = 6, p = 0.0016, Fig. 4f ).
Hbegf knockout mice causes dysfunctional learning
behavior and impulsivity
To investigate whether disruption of the complex infers
on the learning behavior in male mice, contextual and
cued fear conditioning tests were performed. Hbegf cKO
mice showed decreased basal and foot shock (with
tone)-induced freezing behavior in the training session
in the square chamber. Data were analyzed by repeated
measures one-way ANOVA, F(1, 17) = 65.81, p < 0.0001
(Fig. 5a). In the retention test after 24 h, assessing freez-
ing behavior in the square chamber to evaluate context-
ual memory, there was a significant decrease in the
performance of cKO mice (repeated measures one-way
ANOVA: F(1, 17) = 13.90, p = 0.0017, Fig. 5b). In the ex-
periment to evaluate cue-dependent freezing behavior,
mice were put in the rectangular chamber and a cue was
given at 140 s after the start of the experiment, because
the difference in the initial freezing between control and
cKO mice disappeared at 100–140 s. Cue-dependent
freezing during the period 140–200 s after the start of
the experiment was significantly lower in cKO mice than
in control mice (repeated measures one-way ANOVA:
F(1, 17) = 18.25, p = 0.0005, Fig. 5c). We therefore calcu-
lated activity suppression ratio [31, 32] in contextual
Fig. 3 Hbegf deficiency decreases hippocampal NMDA-R expression and plasticity. a, Altered protein expression. Immunoblotting for NMDA
receptor subunits (NR1, NR2A and NR2B), PSD-95 and β-tubulin in the hippocampi of control and cKO mice. n = 8 (Control), n = 8 (cKO).b,
Micrograph and schematic illustration of a hippocampal slice placed onto the multi-electrode dish. c, Representative traces of fEPSPs before and
after the theta burst stimulation. The fEPSPs before and 30 min after the theta burst stimuli are indicated by black and red lines, respectively.
d, Time course of normalized fEPSP amplitude after theta burst stimulation. n = 9 (Control), n = 7 (cKO). All results are presented as means ± s.e.m
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testing, and also cued testing. There were significant in-
creases in the activity suppression ratio in the contextual
testing (Cont: 0.2069 ± 0.02146; cKO: 0.2899 ± 0.01623;
Student’s t test: t = 3.121, df = 17, p = 0.0062), and in the
cued testing (Cont: 0.1686 ± 0.03371; cKO: 0.3093 ±
0.02577; Student’s t test: t = 3.356, df = 17, p = 0.0037)
(Fig. 5d). Learning/memory in Hbegf cKO mice was also
observed in the step-through type passive avoidance
(PA) test (Fig. 5e, f ). The cKO mice showed a signifi-
cantly decreased latency in the test schedule (Student’s t
test: Cont: 555.7 ± 21.72 s; cKO: 380.1 ± 44.46 s; t =
3.476, df = 29, p = 0.0016, Fig. 5f ), but not in the training
session (Student’s t test: Cont: 90.87 ± 22.92 s; cKO:
80.50 ± 21.49 s; t = 0.3303, df = 29, p = 0.7435, Fig. 5e).
Next, we determined whether dysfunctional learning
behavior in male Hbegf cKO mice has associations with
anxiety and impulsivity, as tampering with chemical
communication in the hippocampus is reported to inter-
fere with motivational, emotional and cognitive pro-
cesses in animals [33]. Locomotor activity was tested in
the subjects using the square open-field (OF) test. The
center area was defined as the dark field (#) in the
square chamber, as depicted in Fig. 5g. Hbegf cKO mice
showed increased spontaneous activity in the marginal
Fig. 4 Hbegf deficiency aters neurogenesis in Hbegf cKO mice. a Representative pictures of BrdU-positive neurons. The specimens show BrdU-positive
neurons in the subgranular zone (SGZ), subventricular zone (SVZ), rostromedial striatum (RMS) and olfactory bulb (OLF). Scale bar: 100 μm. b Comparison
of the numbers of BrdU-positive neurons. c Representative pictures of detailed localization of doublecortin (DCX)-positive immature neurons in the
dentate gyrus. d Sub-localization analysis of DCX-positive immature neurons. #1 (between of hilus and SGZ), #2 (SGZ and inner 1/3 of region of granular
cell layer/GCL), #3 (medial 1/3 of GCL), #4 (outer 1/3 of GCL), #5 (molecular layer/MOL). e, f Quantitative analysis of the number of DCX-positive cells and
their relative positions in dentate gyrus. e Total number of DCX positive cells in DG. f The number of DCX positive cells in each layer (#1 - #5). n= 4
(Control), n= 4 (cKO). *p <0.05 (control versus cKO). Values are the means ± s.e.m
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region of the test chamber (Fig. 5h). Significant hyper-
activity was observed in the time course of moving time
(repeated measures one-way ANOVA: F(1, 46) = 13.32,
p = 0.0007, Fig. 5i), total moving time (Student’s t test:
Cont: 834.1 ± 29.40 s; cKO: 1073 ± 60.34 s; t = 3.649,
df = 46, p = 0.0007, Fig. 5j), moving distance every
5 min throughout 60 min (repeated measures one-
way ANOVA: F(1, 46) = 11.70, p = 0.0013, Fig. 5k), total
moving distance (Student’s t test: Cont: 18126 ± 754.4 cm;
cKO: 25397 ± 2061 cm; t = 3.421, df = 46, p = 0.0013,
Fig. 5 Learning and psychomotor disability in Hbegf cKO mice. a-d, Impaired learning and memory in the context and cued fear conditioning
test. Freezing behavior was observed and shown as the percentage of freezing time. a For conditioning, mice were placed in a conditioning
chamber and given three sets of CS and co-terminating US. n = 9 (Control), n = 10 (cKO). b Twenty-four hours after conditioning, contextual
memory was evaluated for 3 min in the chamber used for conditioning. c In the cued test, mice were placed in the novel chamber for 2 min,
then exposed to a CS for another 2 min. d Activity suppression ratio in contextual and cued testing. e and f, Impaired learning and memory in
the step through type passive avoidance (PA) test. e In the training session, learning and memory functions in control and cKO mice were
assessed based on escape latencies in the PA test. n = 15 (Control), n = 16 (cKO). f In the retention test 24 h after training, maximum latency was
set as 600 s. g-q Hyperactivity was evaluated in Open-field test. g Schematic diagram showing the center area. The center area is defined as the
central 4 × 4 division of the 8 × 8 division of all chamber fields, as shown in the schematic diagram (#, center area). h Representative moving
traces in the open field (OF) test. n = 25 (Control), n = 23 (cKO). Results represent the time course of moving time every 5 min throughout 60 min:
(i), total moving time: (j), moving distance every 5 min throughout 60 min: (k), total moving distance: (l), numbers of right turns: (m) and left
turns: (n), time course of center time (%) every 5 min throughout 60 min: (o), total center time (%): (p), moving velocity throughout 60 min: (q).
r, Typical photographs of impulsive behavior in the cliff avoidance (CA) test. Control mice normally avoid the edge of platform so as not to fall,
and do not attempt to jump off (left). Hbegf cKO mice often fall (middle) or jump off (right). s, Immobility time on the platform in the CA test.
n = 10 (Control), n = 12 (cKO). Values are the means ± s.e.m
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Fig. 5l), and numbers of right (Student’s t test: Cont:
1840 ± 78.60; cKO: 2155 ± 61.30; t = 3.122, df = 46, p =
0.0031, Fig. 5m) and left turns (Student’s t test: Cont:
1747 ± 67.31; cKO: 2091 ± 66.81; t = 3.621, df = 46, p =
0.0007, Fig. 5n). While we observed a significant de-
crease in center time every 5 min throughout 60 min
(repeated measures one-way ANOVA: F(1, 46) = 4.749,
p = 0.0345, Fig. 5o) and total center time (%) (Stu-
dent’s t test: Cont: 13.27 ± 1.442; cKO: 9.436 ± 0.9503;
t = 2.179, df = 46, p = 0.0345, Fig. 5p), no change in
moving velocity (Student’s t test: Cont: 21.89 ±
0.3297; cKO: 23.14 ± 0.6017; t = 1.874, df = 46, p =
0.0673, Fig. 5q) was recorded. These data suggest that
Hbegf cKO mice exhibited hyperactivity and anxiety-like
behavioral phenotypes as previously reported [13]. Further-
more, cliff avoidance (CA) test was used to evaluate impul-
sivity [34]. Most of the control mice (n = 12) showed
approximately 1 min-long exploratory behavior on the plat-
form of the transparent plexiglas cylinder, followed by lon-
ger staying in the center for 406.0 ± 9.893 s, while cKO
mice (n = 10) showed a shorter latency time to fall or jump
from the platform (154.8 ± 47.77 s, Student’s t test: p =
0.0001, Fig. 5r, s). There is a possibility that the shorter la-
tency of cKO mice to fall or jump from the platform in the
cliff avoidance test is attributed to their hyperactivity. How-
ever, as cKO mice always first look into the floor and fall
from the platform, they unlikely fall by excessive moving.
This view may be supported by the evidence that no signifi-
cant change in the moving velocity of cKO mice, despite
significant increases in total moving time, total distance
and number of turns were observed.
Hbegf cKO mice exhibit decreased social-behavioral
pattern
While hyperactivity and impulsivity are good predictors
of ADHD [12, 13, 33], development of ADHD in turn
negatively correlates with social interaction [35], but
positively correlate with anxiety and depressive episodes
[36]. The marble-burying (MB) test has been described
as suitable for predicting obsessive-compulsive disorder
(OCD) [37]. Interestingly, in this study, while control
mice buried an average of 12.78 ± 0.7954 (n = 9) glass mar-
bles out of 25 during a-30 min test, Hbegf cKO mice bur-
ied 20.11 ± 0.5638 (n = 9, Student’s t test: t = 7.521, df = 16,
p < 0.0001, Fig. 6a-c). Thus, it is suggested that ablation of
hippocampal Hbegf may confer obsessive-compulsive-like
behavioral traits on the subjects. Given that increased MB
activity as observed here is symptomatic of OCD, we
sought to establish further that Hbegf cKO mice thor-
oughly exhibited anti-social activities using the nest build-
ing (NB) test [38]. In this test, control mice shredded the
cotton plank (Nestlets®) and successfully built a nest that
was taller than the height of the mouse, while cKO mice
scattered the shreds of cotton without building a nest
(Student’s t test: Cont: 0.1350 ± 0.03753 g; cKO: 1.238 ±
0.1807 g; t = 5.973, df = 6, p = 0.001, Fig. 6d). In quantitative
analysis, higher levels of unused Nestlets (Student’s t test:
Cont: 0.1350 ± 0.03753 g; cKO: 1.238 ± 0.1807 g; t = 5.973,
df = 6, p = 0.001, Fig. 6e) and lower scores (Student’s t test:
Cont: 5.000 ± 0.0; cKO: 3.250 ± 0.2500; t = 7.000, df = 6, p =
0.0004, Fig. 6f) on nest rating scales were observed in cKO
mice. Next, maternal behavioral pattern was investigated.
Although there was no significant difference in the frequen-
cies of primiparous mice between control and Hbegf cKO
mice (Cont: 9.600 ± 0.5099, cKO: 9.600 ± 0.7483, p >
0.9999, Fig. 6g), the survival ratio per delivery at day 7 after
birth was markedly decreased in female Hbegf cKO
mice (Student’s t test: Cont: 84.64 ± 6.248 %; cKO:
24.18 ± 11.77 %; t = 4.538, df = 8, p = 0.0019, Fig. 6h).
When we examined the shredded bedding materials, fe-
male control animals built crater-shaped nests made of
shredded bedding materials, while female Hbegf cKO mice
did not (Fig. 6i). Furthermore, female Hbegf cKO mice
failed to gather all 24-h-old pups (Fig. 6j), which had been
put in the center of cage, into the nest (retrieving behav-
ior) at the edge of cage at the time point of 1 h and even
at 2 h in contrast to the control group. Additionally, fe-
male Hbegf cKO dams showed a lack of nursing (lactation
behavior, Fig. 6k), and their pups showed delayed growth
at postnatal day 4 (Fig. 6l) and decreased survival (log-
rank test, χ2 = 27.12, ***p < 0.0001, Fig. 6m). These features
suggest that female Hbegf cKO dams showed “pup neg-
lect”-traits.
NMDA mimetics reverse behavioral abnormalities in
Hbegf cKO mice
From the foregoing, Hbegf cKO mice have shown clear
signs of altered social, parental, anxiety-like and loco-
motor behaviors. To examine whether these phenotypes
are related to altered HB-EGF/ErbB4–PSD-95–NMDA
receptor signaling, we tested two positive allosteric mod-
ulators (PAMs) of NMDA receptor, D-cycloserine [39]
and nefiracetam [40, 41], since D-cycloserine has been
reported to prevent relational memory deficits and sup-
pression of LTP in the hippocampus [42] and nefirace-
tam administration is known to improve depressive
behaviors [43]. In addition, we also examined the effects
of atomoxetine (representative ADHD medicine), which
exhibits dual norepinephrine transporter (NET) inhib-
ition [44] and NMDA receptor antagonism [45]. All
drugs were administered once daily for seven consecu-
tive days, and behavioral tests were performed 24 h after
the last administration (Fig. 7a).
In the OF test, D-cycloserine, nefiracetam and ato-
moxetine reversed the hyperactivity in male Hbegf cKO
mice in terms of total moving time (ANOVA followed
by a post hoc Tukey’s test: F(4, 89) = 8.039, Fig. 7b) and
total distance moved (ANOVA followed by a post hoc
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Tukey’s test: F(4, 89) = 6.687, Fig. 7c). The decreased total
center time, however, was not affected by any of these
three compounds (ANOVA followed by a post hoc
Tukey’s test: F(4, 89) = 6.829, Fig. 7d). *p < 0.05, **p < 0.01,
and ***p < 0.001 versus Control-Saline, #p < 0.05, ##p <
0.01, and ###p < 0.001 versus cKO-Saline. In the CA test,
all three compounds reversed the impulsivity (ANOVA
followed by a post hoc Tukey’s test: F(4, 98) = 13.21, p <
0.001 versus Control-Saline, ###p < 0.001 versus cKO-
Saline, Fig. 7e). In the contextual space memory-related
task, both D-cycloserine and nefiracetam, but not ato-
moxetine significantly reversed this indication in male
Hbegf cKO mice (ANOVA followed by a post hoc
Tukey’s test: F(4, 48) = 7.918, **P < 0.01 versus Control-
Saline, ##p < 0.01, and ###p < 0.001 versus cKO-Saline,
Fig. 7f ). Similar results were also observed in the cue-
conditioning test (ANOVA followed by a post hoc
Tukey’s test: F(4, 48) = 11.67, **p < 0.01 versus Control-
Saline, #p < 0.05, and ###p < 0.001 versus cKO-Saline,
Fig. 7g). In the contextual testing, increased activity sup-
pression ratio in cKO mice was significantly reversed by
D-cycloserine or nefiracetam, but not by atomoxetine
(ANOVA followed by a post hoc Tukey’s test: F(4, 48) =
4.037, *p < 0.05 versus Control-Saline, #p < 0.05 versus
cKO-Saline). Similarly in the cue-dependent testing, in-
creased suppression ratio in cKO mice was also signifi-
cantly reversed by D-cycloserine or nefiracetam (ANOVA
followed by a post hoc Tukey’s test: F(4, 48) = 7.379, *p <
0.05 versus Control-Saline, #p < 0.05, and ###p < 0.001
versus cKO-Saline) (Fig. 7h).
In the PA test, all three compounds had no effect on
latency in the training task (ANOVA: F(4, 63) = 1.592, p =
0.1874, Fig. 7i). At the test session, atomoxetine further
shortened the latency, suggesting this action is inde-
pendent of the inhibition of hyperactivity (ANOVA
followed by a post hoc Tukey’s test: F(4, 63) = 6.511, *p <
0.05 and ***p < 0.001 versus Control-Saline, Fig. 7j), on
the other hand, D-cycloserine and nefiracetam showed
an insignificant tendency to reverse the decreased latency
in male cKO mice. In the MB test, both D-cycloserine and
nefiracetam but not atomoxetine reversed this abnormal
behavior in male Hbegf cKO mice (ANOVA followed by a
post hoc Tukey’s test: F(4, 74) = 29.24, ***p < 0.001 versus
Control-Saline, ###p < 0.001 versus cKO-Saline, Fig. 7k, l).
In the NB test, D-cycloserine and nefiracetam abolished
the abnormal behavior in terms of the levels of nest rating
(ANOVA followed by a post hoc Tukey’s test: F(4, 42) =
19.92) and unused Nestlets (ANOVA followed by a post
hoc Tukey’s test: F(4, 42) = 20.09), whereas atomoxetine
worsened this behavior (Fig. 7m-o). ***P < 0.01 versus
Control-Saline, #p < 0.05, ##p < 0.01, and ###p < 0.001 ver-
sus cKO-Saline. From the foregoing, atomoxetine had no
effect on abnormal MB activity whilst worsening nest-
building activity. In contrast, D-cycloserine and nefirace-
tam significantly reversed these abnormal behaviors, thus,
indicating that the pathophysiological mechanisms and
pharmacological actions in the MB and NB tests appear to
be independent of hyperactivity and its regulation.
Neurobiology of therapeutic actions
We have demonstrated that the alteration in social, par-
ental, and locomotor behaviors and anxiety-like pheno-
types in male Hbegf cKO mice has links with changes in
neurobiological assembly of PSD-95 [27]/NMDA-receptor
NR2 subunit [28] in the hippocampus. Next, we sought to
examine whether the observed reversal of behavioral phe-
notypes in Hbegf cKO mice by D-cycloserine and nefirace-
tam has direct implication on the ErbB/PSD-95/NMDA
receptor signaling. Indeed, hippocampus samples derived
from male Hbegf cKO mice showed a marked decrease in
the levels of phosphorylation of ERK1/2 and NR1, and in
the protein levels of NR1, NR2B and PSD-95 (Fig. 8a). As
shown in Fig. 8b, both D-cycloserine and nefiracetam [46]
significantly increased the phosphorylation level of ERK1,
ERK2 and NR1 over saline-treated Hbegf cKO group
(ANOVA followed by a post hoc Tukey’s test: p-ERK1: F(3,
16) = 10.62, p-ERK2: F(3, 16) = 15.91, p < 0.0001, p-NR1: F(3,
16) = 6.019, total NR1: F(3, 16) = 10.64, NR2B: F(3, 16) =
6.323, and PSD-95: F(3, 16) = 20.08, * p < 0.05, ** p < 0.01,
and *** p < 0.001 versus Control-Saline, # p < 0.05, ## p <
0.01, ### p < 0.001 versus cKO-Saline). Similarly, the treat-
ments increased PSD-95 expression but not NR1 and
NR2B over the saline-treated male Hbegf cKO group. Im-
munohistochemical analysis revealed that both D-
(See figure on previous page.)
Fig. 6 Increased obsessive behavior and decreased social activity in Hbegf cKO mice. a-c Obsessive behavior evaluated by the marble burying
(MB) test. a, The burying behavior was evaluated when 2/3 of a marble was buried in the bedding. b Representative pictures of the results of the
MB test 30 min after the start of the experiment. c, Quantitative comparison of MB behavior. n = 9 (Control), n = 9 (cKO). d-f Social activity as
evaluated by the nest building (NB) test. d, Representative pictures of the nest after overnight performance in a new cage. The arrow represents
the unused materials. The asterisk represents the position where the mouse sleeps. Unused Nestlet materials were determined by weight: (e) and
the 1–5 rating scale: (f) n = 4 (Control), n = 4 (cKO). g-m Impairment of maternal behavior in female Hbegf cKO mice. n = 5 (Control dams), n = 5
(cKO dams). g Lack of change in the numbers of primiparous mice. h Decreased number of surviving pups at 7 days after birth. i Representative
pictures of the nest in terms of shredding beddings (arrow). j Representative pictures showing the lack of maternal retrieving. k Lack of intragastric
breast milk in neglected pups of Hbegf cKO mice. The arrow indicates signs of intragastric breast milk. l Hypotrophy in the pups of Hbegf cKO dam
mice. Representative picture of a mouse at postnatal day 4.m Survival ratio. The percentage of surviving pups was evaluated over 7 days. n = 48 (pups
of control mouse), n = 48 (pups of cKO dam mouse). Values are the means ± s.e.m
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cycloserine and nefiracetam mainly reversed the decrease
in phosphorylation of ERK1/2 at the level of mossy fiber of
the hippocampus (Fig. 8c).
Chronic treatments with nefiracetam, but not D-
cycloserine (Fig. 9a), reversed the decrease in neuro-
genesis in terms of the numbers of BrdU-positive
cells in the SGZ of male Hbegf cKO mice (Fig. 9b, c).
Data were analyzed with ANOVA followed by a post
hoc Tukey’s test: F(3, 12) = 22.59, **p < 0.01 versus
Control-Saline, #p < 0.05 versus cKO-Saline. Moreover,
the abnormal appearance of DCX-positive cells in the
middle to outer layer of the GCL instead (layers 3–5)
of male Hbegf cKO mice was significantly and par-
tially reversed by nefiracetam and D-cycloserine,
Fig. 7 Pharmacological amelioration of behavioral dysfunctions in Hbegf cKO mice. a, Time schedule of drug treatments and behavioral tests. b-d,
Effects of compounds on hyperactivity and anxiety in the OF test. Results are shown as moving time: (b), moving distance: (c) and center time:
(d) in the OF test. n = 23, 24, 18, 15, and 14, respectively, for Control-Saline, cKO-Saline, cKO-Atomoxetine, cKO-D-cycloserine, and cKO-Nefiracetam.
e, Effects on impulsive behavior. Immobility times on the platform (s) were evaluated in the CA test. n = 23, 27, 19, 18, 16, respectively, for the groups
mentioned above. f-h, Effects on dysfunction in contextual-: (f) and cue-exposed freezing: (g), and activity suppression ratio: (h) using the fear
conditioning test. All data are shown as the percent of total freezing. n = 8, 9, 10, 16, 10, respectively, for the groups mentioned above. i and j, Effects
on memory deficit using the step-through passive avoidance (PA) test. In the training session, each chronic drug administration did not change the PA
latency: (i). Atomoxetine further decreased the PA latency in Hbegf cKO mice, while the decrease induced by D-cycloserine and nefiracetam was slight,
but not significant: (j). The numbers of animals used were 10, 14, 10, 16, and 18, respectively. k and l, Effects on the obsessive behavior in Hbegf cKO
mice. Both D-cycloserine and nefiracetam, but not atomoxetine reversed obsessive behavior in the MB test. Representative pictures of the results of
the MB test 30 min after the start of the experiment: (k). Quantitative comparison of the numbers of buried marbles: (l). The numbers of animals used
were 12, 18, 18, 15, and 16, respectively.m-o, Effects on decreased social activity. Typical pictures of differential pharmacological effects on nest
building behavior: (m). Quantitative comparison on the rating scale: (n) and the levels of unused Nestlets: (o). The numbers of animals used were 8, 9,
8, 16, and 6, respectively. Values are the means ± s.e.m
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respectively (ANOVA followed by a post hoc Tukey’s test:
F(3, 15) = 7.322, *p < 0.05 versus Control-Saline, ##p < 0.01
versus cKO-Saline, Fig. 9d, e).
Discussion
Previous study [13] has reported that there was a psychi-
atric disorder in conditional Hbegf KO mice using Six3-
Cre mice, whose gene expression is widely distributed in
retina and ventral forebrain including basal ganglia,
medial amygdaloid area, hypothalamus, olfactory bulb
and septum [47]. The ventral forebrain cKO mice show-
ing Hbegf gene disruption in prefrontal cortex and
hippocampus manifest hyperactivity and decreased pre-
pulse inhibition, which were reversed by typical and
atypical antipsychotics in behavioral studies [13]. In
addition, the ventral forebrain cKO mice showed disor-
ders in social activity and working memory, which is
related to forebrain dysfunction. The mice also showed
decreased levels of NMDA receptor-related signaling
only in the prefrontal cortex, though it remained elusive
whether these changes occur in the hippocampus. In the
present study, we successfully generated hippocampal
Hbegf cKO mice, by crossbreeding floxed Hbegf and
Gng7-Cre knock-in mice. The specificity was observed in
the transcription study, which shows a selective decrease
of Hbegf gene expression in hippocampus, but not in
olfactory bulb, striatum, cortex or cerebellum.
To characterize the phenotypes of hippocampal cKO
mice we performed various cellular and molecular bio-
logical studies. First, we examined the NMDA receptor
signaling, which is augmented through ErbB4 receptor,
the target for HB-EGF [7]. Significant decrease was ob-
served in the protein expression of NR1, NR2B and
PSD-95, but not NR2A in the hippocampus, being in
contrast to the case with ventral forebrain Hbegf cKO
mice, where the decrease was observed only in NR1 and
PSD-95, but not NR2A or NR2B in the prefrontal cortex
[13]. Hippocampal Hbegf cKO mice also showed signifi-
cant decreases in the phosphorylation levels of ERK1/2,
NR1, which are closely associated to the NMDA signal-
ing. Lack of Hbegf gene in hippocampal neurons induced
a reduced LTP based on Schaffer collateral-CA1 path-
way, which is closely related to NMDA receptor func-
tions, in the experiment using multi-electrode arrays.
However, by using this apparatus we could not detect
the LTP based on perforant path-DG and mossy fiber-
Fig. 8 Neurobiological effects of D-cycloserine and nefiracetam in Hbegf cKO mice. a-c, Effects of D-cycloserine and nefiracetam on the decrease
in levels of p-ERK1, p-ERK2, p-NR1, total NR1, NR2B and PSD-95. Schedule of drug treatments were the same as in Fig. 6a. Results represent typical
pictures of western blot analysis: (a), and quantitative comparisons: (b). n = 5 (all groups). Values are the means ± s.e.m. Typical pERK1/2-like
immunohistochemical pictures in the hippocampus: (c)
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CA3 pathways, which are related to NMDA receptor
and metabotropic glutamate receptors function, respect-
ively [48–50]. Known electrophysiological studies using
microelectrodes would be necessary to see LTP based on
these pathways as the next subjects. It should be noted
that hippocampal cKO mice showed a significant reduc-
tion in neurogenesis evaluated by BrdU-labelling only in
the SGZ of DG, but not in the SVZ, RMS or OLF,
compared with control mice. Furthermore DG of hippo-
campal cKO mice also showed a mis-positioning of im-
mature neurons stained with DCX, being consistent
with the previous report that HB-EGF plays roles in the
maturation of neurons as a growth factor, and enhances
neurogenesis in the SGZ [14].
In the behavioral studies, the cKO mice showed a dys-
function in learning behavior in the contextual and cued
fear conditioning tests, where the hippocampus plays
key roles. The Hbegf cKO mice showed significant de-
creases in baseline freezing without a foot shock or
sound, and in freezing in the contextual task after train-
ing. An important argument arises that lower basal
freezing level in hippocampal cKO mice is responsible
for the decreased retention activity in fear conditioning
test. However, the increase of activity suppression ratio
in the contextual and cue-dependent testing was both
significant after normalization. Furthermore, as these
mice did not show any significant difference in the EPW
test, the possibility that cKO mice are less responsive to
electrical footshock would not be supported. Taking into
account that passive avoidance activity in the PA test
was decreased in hippocampal cKO mice, they appar-
ently manifest the loss of learning activity. Significant
decrease in the total center time may indicate that cKO
mice show anxiety-like behavioral phenotype. However,
the possibility cannot be excluded that hyperactivity may
affect this phenotype. Impulsivity or the reduction of im-
mobility time due to fall or jump does not seem to be
simply attributed to the hyperactivity, since no signifi-
cant change in the velocity in the OF test was observed
and cKO mice always first look into the floor before fall-
ing from the platform. Thus, the cKO mice appear to
show both hyperactivity and impulsivity, which are
major symptoms observed in ADHD patients, along with
cognitive dysfunction [51].
OCD, characterized by obsessive symptoms, on the
other hand, was also demonstrated in the cKO mice. In
the present study, the cKO mice showed excessive mar-
ble burying activity and lower nest-building ability,
which represent obsessive-like behavior and social activ-
ity, respectively, for which normal hippocampal function
Fig. 9 Improvements in decreased neurogenesis and abnormal sub-localization of DCX-positive neurons in Hbegf cKO mice. a, Time schedule for
drug treatments and sample preparation. b and c, Representative pictures of BrdU-staining following D-cycloserine or nefiracetam-treatments:
(b) and quantitative comparisons: (c). n = 4 (all groups). **p < 0.01 versus Control-Saline, #p < 0.05 versus cKO-Saline. Values are the means ± s.e.m.
d, Representative pictures of DCX-staining following D-cycloserine or nefiracetam-treatments. e, Effects of D-cycloserine and nefiracetam on
mis-positioning of DCX-positive neurons in GCL and MOL of DG of cKO mice. Results were represented as % ratio of mis-positioned DCX-positive
neurons (#3-5 layers) to total number of cells in each slice. *p < 0.05 (control-saline versus cKO-saline), ##p < 0.05 (cKO-saline versus cKO-nefiracetam).
The numbers of animals used were 5, 5, 4, and 5, respectively. Values are the means ± s.e.m
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is required [52–54]. As these abnormalities were not
improved by atomoxetine, which inhibited hyperactivity
and impulsivity, excessive marble burying activity and
lower nest-building ability may not be attributed to
hyperactivity. Additionally, the cKO mice also showed
lower levels of maternal behaviors, such as retrieving
and nursing (lactation behavior), which is defined as
“pup neglect”.
Tourette syndrome is a neurodevelopmental condition
characterized by multiple motor and vocal tics, often ac-
companied by behavioral symptoms, which may manifest
as complex clinical features [55]. Large clinical studies
indicate that many Tourette syndrome patients (esti-
mated to be ~60 %), have a psychiatric comorbidity such
as ADHD and OCD [56]. Although the assessment of
vocal and motor tics is important, Hbegf cKO mice may
manifest comorbid psychiatric features of Tourette syn-
drome. ADHD, OCD and Tourette syndrome are con-
sidered to be developmental diseases, which often
appear in childhood [57, 58]. As the levels of HB-EGF
are highly expressed in neurons in the embryonic and
neonatal rodent brain, followed by a gradual decline with
age in in situ studies [20], low HB-EGF levels in an early
developmental stage may play key roles as a cause of
psychiatric disorders. The findings that HB-EGF plays
roles in the maturation of neurons as a growth factor,
and enhances neurogenesis in the SGZ [12, 14], suggest
possible roles for this factor in normal psychiatric devel-
opment and learning activity.
Social withdrawal, cognitive and psychiatric abnormal-
ities exhibited by Hbegf cKO mice are similar to those
observed in mice lacking neurexin-1α gene (well charac-
terized in autism and schizophrenia) [59], synaptosomal-
associated protein 25 (SNAP-25) gene (Coloboma mouse
mutant) [60] and dopamine active transporter (DAT)
KO mice (animal model of ADHD) [61]. This study pro-
vided evidence suggesting that psychiatric abnormalities
in Hbegf cKO mice may be related to the alteration in HB-
EGF/ErbB4–PSD-95–NMDA receptor signaling, since
HB-EGF is known to activate NMDA receptors [62] con-
centrated and anchored at the synapse via PSD-95 scaffold
[28] and PAMs of NMDA receptor such as D-cycloserine
[39] and nefiracetam [40, 41] aptly reversed NMDA recep-
tor signaling modulation and all behavioral abnormalities
tested except in the OF test. Specificity was observed in
the finding that representative ADHD medicine atomoxe-
tine inhibited only hyperactivity and impulsivity, but not
learning/memory or social behavioral abnormalities.
These pharmacotherapeutic differences support the view
that learning/memory, impulsivity or social abnormalities
are not simply attributed to the hyperactivity of cKO mice.
Both PAMs significantly reversed NMDA receptor signal-
ing, such as decreased phosphorylation of ERK1/2, NR1
and down-regulation of NR1, NR2B and PSD-95, though
it remains elusive whether these pharmacological actions
underlie the therapeutic actions against behavioral abnor-
malities. As PAMs markedly reversed the decreased ERK1/
2 phosphorylation in the mossy fiber of cKO mice, further
pharmacological studies on LTP and NMDA receptor
signaling using sub regions of hippocampus should be
necessary as the next subjects.
D-cycloserine is known to bind the glycine-binding
site on the NMDA receptor NR1 subunit [63], and to
play a partial agonist role [39, 42]. The choice of D-
cycloserine was informed by previous findings that this
compound showed preclinical benefits in Neuroligin 1
KO mice (human autism and mental retardation) [64] and
Tourette syndrome with accompanying ADHD and/or
OCD [65]. The present study revealed that D-cycloserine
significantly inhibited the ADHD- and OCD-like behav-
ioral phenotypes as well as the learning disabilities in
Hbegf cKO mice. Similar results were observed with nefir-
acetam, another PAM of NMDA receptors via the glycine-
binding site [40, 41, 46]. Recently we have clarified the
mode of nefiracetam binding to NR1 subunit by a molecu-
lar dynamics simulation study, in which nefiracetam first
binds to a novel site of NR1 and causes a release of
glycine, followed by the direct binding (replacement) to
the glycine pocket [41].
The reduction in SGZ neurogenesis was selectively re-
versed by nefiracetam, but not by D-cycloserine. The
mechanisms underlying the nefiracetam-selective reversal
may be in part attributed to the differential modes of ac-
tion to NR1, as above-mentioned. However, the possibility
of non-NMDA receptor-based mechanisms cannot be
excluded, and there is a report that nefiracetam increases
the number of immature neurons expressing polysialy-
lated neural cell adhesion molecule (PSA-NCAM) in the
DG, possibly through an action on nicotinic acetylcholine
receptors [66]. Nevertheless, nefiracetam significantly, and
D-cycloserine partially reversed the abnormal expression
of DCX-positive neurons in the SGZ and DG of Hbegf
cKO mice, where some DCX-positive neurons were
observed at the inner part of DG, suggesting both PAMs
reverse the abnormal maturation of newly born neurons.
The further studies are necessary whether these
pharmacological actions are mediated though NMDA
receptor signaling or whether pharmacologically im-
proved neurogenesis and neuronal maturation are in-
volved in the pharmacotherapeutic actions against
behavioral abnormalities.
Conclusions
In the present study, we demonstrate that the hippo-
campal Hbegf cKO mouse is a unique model mani-
festing experimental ADHD/OCD-like behavioral
phenotypes. Additionally, PAM of NMDA receptor
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would be one of promising candidates to cure related
pathologies.
Methods
Generation of hippocampal neuron-specific Hbegf-deficient
mice (Gng7 wt/cre; Hbegf flox/flox)
All experimental protocols were approved by the Nagasaki
University Animal Care Committee (Nagasaki, Japan), and
were performed in accordance with approved guidelines
and regulations. We generated a mutant strain of hippo-
campal neuron-specific knockout (KO) mice using a Cre-
lox-mediated conditional Hbegf KO approach with the
Gng7 promoter. The generation of floxed Hbegf knock-in
mice [17] and Gng7-Cre knock-in mice [18] have been de-
scribed previously. Regarding the genetic background of
mice, the sub strain is C57BL/6J and mice were back-
crossed onto a C57BL/6J line for at least ten generations.
Hbegf flox/flox mice were obtained by interbreeding the
Hbegf wt/flox mice. Hbegf flox/flox mice were bred with Gng7-
Cre knock-in mice to generate Gng7 wt/cre; Hbegf wt/flox
mice. Subsequently, Gng7 wt/cre; Hbegf wt/flox mice were
bred with Hbegf flox/flox mice to generate Gng7 wt/cre; Hbegf
flox/flox mice (Hbegf cKO mice). We used male mice carry-
ing the Gng7-Cre transgene for breeding to avoid an influ-
ence on maternal behavior by genetic modifications. The
Gng7-Cre allele was identified by PCR using the primers
5′-GGCGACGTTGTTAGTACCTGAC-3′, 5′-ATCCCT
GAACATGTCCATCAGGTTC-3′ and 5′-TATAGGTA
CCCAGAAGTGAATTCGGTTCGC-3′. Also, the floxed





It would be highly desirable that Gng7 wt/wt; Hbegf flox/
flox, Gng7 wt/cre; Hbegf wt/wt, and Gng7 wt/wt; Hbegf wt/wt
are used as the littermate control of Gng7 wt/cre; Hbegf
flox/flox (Hbegf cKO) mice. Due to the practical difficulty
of use of all these littermate controls, male Gng7 wt/cre
mice were used as controls for male Hbegf cKO mice to
rule out a possible influence of genetic background,
since former mice showed no significant change in psy-
chomotor activity, compared with wild-type mice [26].
All mice were used at 10–16 weeks of age and kept in
a room with a temperature of 21 ± 2 °C with ad libitum
access to a standard laboratory diet and tap water in
standard animal cages in a 12-h light/dark cycle (lights
on at 08:00).
Quantitative real-time polymerase chain reaction (qPCR)
Total RNA was extracted from each brain regions; olfac-
tory bulb, striatum, cortex, hippocampus, and cerebellum
using RNAeasy micro kit (QIAGEN, Hilden, Germany),
and 500 ng of RNA was used for cDNA synthesis. qPCR
was performed with GeneAce SYBR qPCR mixα (NIP-
PON GENE, Tokyo, Japan) using the LightCycler 480 In-
strument II (Roche Diagnostics, Basel, Switzerland). The
following primers were used: Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), 5′-TATGACTCCACTCACG
GCAAAT-3′ (forward) and 5′-GGGTCTCGCTCCTGG
AAGAT-3′ (reverse) Hbegf, 5′- CGGGGAGTGCAGA
TACCTG-3′ (forward) and 5′- TTCTCCACTGGTAG
AGTCAGC −3′ (reverse). Samples were amplified for
50 cycles consisting of 95 °C (15 s), 60 °C (1 min). GAPDH
was used as an internal control for normalization. In all
cases, the validity of amplification was confirmed by the
presence of a single peak in the melting temperature ana-
lysis and by linear amplification with increasing number
of PCR cycles.
Western blot analysis
The hippocampus was sonicated in ice-cold SDS lysis
buffer (50 mM Tris–HCl, pH6.8, 2 % SDS, 10 % glycerol,
1 μM [p-amidinophenyl] methanesulfonyl fluoride
hydrochloride [p-APMSF]). Total protein (20 μg) was
separated on SDS-polyacrylamide gels. Primary anti-
bodies were used after following dilutions: mouse anti-
NR1 antibody (1:500; Upstate, Lake Placid, NY, USA),
rabbit anti-phospho-NR1 antibody (1:500; Upstate),
rabbit anti-NR2A antibody (1:500; Millipore, Billerica,
MA, USA), rabbit anti-NR2B antibody (1:500; Chemi-
con, Temecula, CA, USA), rabbit anti-PSD-95 antibody
(1:500; Chemicon), rabbit anti-p44/42 MAPK (ERK1/2)
polyclonal antibody (1:1000; Cell Signaling Technology,
Danvers, MA, USA), rabbit anti-phospho-p44/42 MAPK
(p-ERK1/2) polyclonal antibody (1:1000; Cell Signaling
Technology), and rabbit anti-β-tubulin polyclonal anti-
body (1:500; Santa Cruz Biotechnology, Dallas, TX,
USA). Horseradish peroxidase-labeled anti-mouse IgG,
and horseradish peroxidase-labeled anti-rabbit IgG were
used as secondary antibodies at a dilution of 1:2000
(Promega, Fichburg, WI, USA). Immunoreactive bands
were detected using an enhanced chemiluminescent sub-
strate (SuperSignal West Pico or Dura Chemilumines-
cent Substrate; Pierce Chemical, Dallas, TX, USA). The
relative densities of the pERK1/2 bands were normalized
to total ERK1/2, while those of NMDA receptor subunit
bands were normalized to β-tubulin.
Histology and immunohistochemistry
Under deep pentobarbital anaesthesia (50 mg/kg, i.p.),
male mice were perfused transcardially with 20 ml of
potassium-free PBS (K+-free PBS, pH 7.4), followed by
50 ml of a 4 % paraformaldehyde (PFA) solution in
potassium-free PBS. Brains were isolated, post-fixed for
3 h, and cryoprotected overnight in a 25 % sucrose
solution. Tissues were fast frozen in cryoembedding
compound in a mixture of ethanol and dry ice and
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stored at −80 °C until use. Brain tissue was cut on a
cryostat at a thickness of 30 μm, and then brain sec-
tions were thawed into the 0.1 % sodium azide stock
solution at 4 °C until use. β-Galactosidase (lacZ) stain-
ing was conducted overnight at 37 °C in PBS containing
5 mM potassium hexacyanoferrate (III), 5 mM potas-
sium hexacyanoferrate (II), 2 mM magnesium chloride
and 1 mg/ml 5-bromo-4-chloro-3-indolyl-β-D-galacto-
pyranoside. Immunohistochemistry was conducted
using brain sections that were washed with TBST
(0.1 % Triton X-100 in TBS). The sections were incu-
bated with blocking buffer containing 3 % bovine serum
albumin in TBST and subsequently reacted with rabbit
anti-phospho-ERK1/2 (1:300) overnight at 4 °C. After
washing, the sections were incubated with second anti-
body, Alexa 488-conjugated anti-rabbit IgG (1:300;
Invitrogen, CA, USA) for 2 h at room temperature.
After further washing, the sections were mounted with
Pristine Mount, and analysed using a structured illumin-
ation microscopy (BZ-X700, Keyence, Osaka, Japan).
Electrophysiological recordings
Brains were rapidly removed from male mice and the
hippocampus region was dissected out. Transverse
hippocampal slices (350 μm thick) prepared using a
vibratome were incubated for 2 h in artificial cerebro-
spinal fluid (ACSF) containing the following (in mM):
124 NaCl, 3 KCl, 26 NaHCO3, 2 CaCl2/2H2O, 1
MgSO4/7 H2O, 1.25 KH2PO4, 10 D-Glucose, pH 7.2–
7.4, bubbled with carbogen gas (95 % O2, 5 % CO2)
at room temperature. After 2 h, a slice was trans-
ferred to 8 × 8 planar multielectrode arrays (electrode
size, 20 μm× 20 μm; interpolar distance, 100 μm;
Panasonic MED-P210A), and maintained submerged
condition at 32 °C, while superfused at 6 ml/min
(using a peristaltic pump) with ACSF used for stor-
age, bubbled with carbogen gas (95 % O2, 5 % CO2).
For recordings, extracellular field excitatory post-
synaptic potentials (fEPSPs) in the Schaffer collateral/
CA1 hippocampal pathway (SC/CA1) synaptically
evoked fEPSPs with a magnitude of 30–40 % of the
maximum response at bipolar constant current pulses
(3–50 μA, 0.1 ms) and were recorded through a 0.1–
10 kHz bandpass filter using a multielectrode record-
ing system (MED64, Alpha Med Sciences) [67]. Before
and after the induction of long-term potentiation
(LTP), test and control pathways were stimulated
every 30 s. After achieving a stable baseline for
10 min, LTP was induced by three trains of theta
burst stimulation, with each theta burst consisting of
a ten-burst train of four pulses (100 Hz) with 200 ms
inter-train intervals. After the theta burst stimulation,
fEPSPs were recorded for at least 30 min.
Design of behavioral experiments
In all experiments, the order of behavioral tests was de-
signed according to the expected degree of stress in-
duced. To avoid cross-test interaction, each test was
performed after a habituation period of 1 week. Only
one behavioral test was performed each day. Further-
more, the same male mice were used for the following
tests; assessment of general health, OF test, rotarod test,
stationary horizontal thin-rod test, CA test, MB test, NB
test, contextual and cued fear conditioning test, and PA
test. In the initial behavioral battery experiments, we
started with n = 6 per each group and performed the
statistical comparison between control and Hbegf cKO
mice. To clarify the reliable significance of the differ-
ence, we performed additional experiments in some
tests. In this case we confirmed that there is no signifi-
cant difference in respective data between the initial and
additional mice, which have been used over a week after
arrival. A different group of female mice was used for
the tests for parity and maternal behavior. Also, inde-
pendent groups of male mice were used for the experi-
ments to determine the effects of drugs.
Assessment of general health
Body weight and rectal temperature (as body temperature)
of 10–16-week-old male control and Hbegf cKO mice
were measured. In the wire hang test, the male mouse was
first placed on a 1 × 1 cm wire mesh. The wire mesh was
then inverted and waved gently, so that the mouse gripped
the wire. Latency to fall was recorded, with a 180 s cutoff
time. The nociception threshold was evaluated by the la-
tency of paw withdrawal upon a thermal stimulus, using a
thermal stimulator (IITC Life Science, CA, USA), as de-
scribed previously [68]. A cutoff time of 20 s was set to
avoid tissue damage. The electrical stimulation-induced
paw withdrawal (EPW) test was performed as described
previously [68, 69]. Briefly, electrodes were fastened to the
plantar surfaces and insteps of male mice. Transcutaneous
nerve stimuli with each of the three sine-wave pulses (5,
250, and 2000 Hz) were applied using a Neurometer®
CPT® system (Neurotron, MD, USA). The minimum in-
tensity (μA) at which each mouse withdrew its paw was
defined as the current stimulus threshold.
Rotarod test
The rotarod test was performed as previously reported
[26]. The rotarod apparatus (MK0610A, Muromachi
KIKAI) was used to measure fore- and hind-limb motor
coordination. During the training period, each male
mouse was placed on the rotarod revolving at a constant
speed (20 rpm) for a maximum of 60 s, and the latency
to fall off the rotarod within this time period was re-
corded. Mice were trained for 3 consecutive days, receiv-
ing four trials per day with a 1 h inter-trial interval.
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During the test period on day 4, mice were tested in four
consecutive 60 s trials at constant speeds of 10, 20, 30
and 40 rpm. The mean latency to fall from the rotarod
(for the four trials at each speed level) was recorded.
Accelerating rotarod test
The accelerating rotarod test was used to measure
motor learning as previously reported [70]. During the
training period, each male mouse was placed on the
rotarod at a constant speed (4.5 rpm), which was accel-
erated to 45 rpm. The maximum observation time was
5 min. Mice were trained for 3 consecutive days, receiv-
ing four trials per day with a 1 h inter-trial interval. Dur-
ing the test period on day 4, mice were tested for seven
consecutive 60 s trials at constant speeds of 5, 12, 18,
25, 31, 40 and 45 rpm. During the constant speed
rotarod experiment, mice were given three trials per day.
The mean latency to fall from the rotarod (for the three
trials at each speed level) was recorded.
Stationary horizontal thin-rod test
The stationary horizontal thin-rod test was used to
measure motor coordination and balance as previously
reported [71]. Each male mouse was placed on the thin-
rod (15 mm in diameter, 50 cm long and placed 40 cm
high to discourage jumping). The thin-rod was flanked
at both ends by a large acryl wall to prevent falling at
the end of the thin-rod. The maximum observation time
was 1 min. Mice were trained for three consecutive days,
receiving four trials per day with a 1 h inter-trial inter-
val. The mean latency to fall from the thin-rod was
recorded.
Step through-type passive avoidance (PA) test
The PA test was performed as described previously [72].
Briefly, the apparatus consisted of an illuminated com-
partment (light room) and a dark one (dark room) con-
nected by a guillotine door. In the training trial, the
male mouse was first placed into the light room and
after 10 s, the partitioning door was opened. When the
mouse entered the dark room, a 2 s footshock at 0.8 mA
was given through the grid floor. Twenty-four hours
after the training trial, the mouse was tested for reten-
tion time by being placed mice into the light room and
the step through latency was measured (maximum la-
tency, 600 s).
Contextual and cued fear conditioning test
The contextual and cued fear conditioning test was per-
formed in a soundproof behavioral apparatus (Muromachi
Kikai, Japan). Male mice were placed in a conditioning
chamber, with a plexiglas front, gray side- and back-walls
and electrical grid floors, and allowed to move freely for
2 min. They then received three pairings of a tone (20 s,
4000 Hz, 80 dB) as a conditioned stimulus (CS), and a co-
terminating footshock (2 s, 0.5 mA) as the unconditioned
stimulus (US), with an inter-stimulus interval of 2 min.
After the last footshock, the mice remained in the condi-
tioning chamber for 2 min. Twenty-four hours after the
conditioning, mice were tested for contextual memory in
the same conditioning chamber for 3 min. The cued test-
ing was performed in a triangular chamber, with a plexi-
glas front, black and white stripe side- and back-walls and
flat floors covered by paper towels. Mice were allowed to
move freely for 2 min, and then received a tone (120 s,
4000 Hz, 80 dB). All experiments were observed using a
video tracking system (Muromachi Kikai, Japan) to record
the moving and freezing behavior of the mice. Freezing
was defined as complete resting, when a mouse does not
move for more than 1 s [73]. The loss of retention activity
was evaluated by the activity suppression ratio in the con-
textual testing using the activity levels during the first
2 min conditioning before a shock delivery and during the
first 2 min contextual testing, according to the formula:
activitytest/(activitytrain + activitytest), as previously reported
[31, 32]. Similarly, in the cue-dependent testing, the sup-
pression ratio was calculated using the activity levels dur-
ing the first 3 min cued testing before cue-exposure and
during the last 3 min after the exposure.
Open field (OF) test
In the OF test, locomotor activity was measured for
60 min in a square chamber (70 × 70 × 30 cm) with a
video tracking system (Muromachi Kikai, Japan). Each
mouse was placed in the corner of a square chamber.
The test was illuminated at 100 lux. Moving time, dis-
tance travelled, and time spent in the center area were
recorded.
Cliff avoidance (CA) test
In the CA test, cliff avoidance and jumping were mea-
sured for 7 min using a round platform (a transparent
plexiglas cylinder with a diameter of 13 cm and a height
of 20 cm). Each male mouse was placed on the platform,
and the jumping behavior was defined as positive per-
forming, while falling from the top was defined as pas-
sive performing [34].
Marble burying (MB) test
In the MB test, each male mouse was placed in an open
plexiglas cage (28 × 45 × 20 cm) with a 5 cm layer of fine
bedding material and 25 equally spaced glass marbles
(17 mm in diameter). The number of buried marbles
was counted after 30 min. When 2/3 of a marble was in
the fine bedding material, it was defined as buried [52].
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Nest building (NB) test
In the NB test, each male mouse was placed into a clean
cage containing fine wood-chip bedding material and
single cotton batting Nestlets® nesting material (2.5 g of
5 cm squares, Ancare, NY, USA) approximately 1 h be-
fore the dark phase. The next morning, unused Nestlet
pieces were weighed and nests were evaluated on a rat-
ing scale of 1–5 [38]. The threshold of unused Nestlet
pieces was more than 0.1 g. The rating scale was defined
as follows: 1, Nestlet not noticeably touched; 2, Nestlet
partially shredded (50–90 % remaining intact); 3, Nestlet
mostly shredded but no identified nest (<50 % of the
Nestlet remaining intact); 4, Nestlet mostly shredded
and a flat nest identified (>90 % of the Nestlet was
shredded and used for the nest); and 5: almost all of the
Nestlet was shredded and the nest was the shape of a
crater with walls higher than mouse body height.
Parity and maternal behavior
Female Hbegf cKO mouse was mated with a male Hbegf
flox/flox mouse. To rule out a possible influence of pups’
genetic background for maternal behavior, female Hbegf
flox/flox mouse was bred with male Hbegf cKO mouse as
control mating. Pregnant mice were individually trans-
ferred to a new cage in the same environment and par-
turition was checked daily in the morning (09:00) and
evening (19:00). The day when parturition was first de-
tected was defined as postnatal day 0 (P0). Maternal be-
haviors were measured on P0 to P7. For the separation
of a dam from her pups, the dam was put in one corner,
while her pups were placed in the center of the same
cage. After separation, maternal behavior, such as re-
trieving and suckling, were observed for 1 and 2 h. For
this experiment, 10–12 weeks-old dams were used.
BrdU- and doublecortin-staining
BrdU (50 mg/kg in sterile saline) was injected intraperi-
toneally [15]. Injections were made once a day for three
consecutive days. For brain tissue preparation, mice were
deeply anaesthetized with sodium pentobarbital (50 mg/
kg, i.p.). Brains were quickly isolated, and washed with
saline and 4 % PFA. Brains were post-fixed in 4 % PFA
for 24 h and finally transferred to 25 % sucrose solution
(in 0.1 M K+-free PBS) overnight for cryoprotection. Fol-
lowing freezing in cryoembedding compound, brain sec-
tions were prepared at 30 μm thickness and were stored
in cryoprotectant solution (25 % ethylene glycol, 25 %
glycerin, 0.05 M phosphate buffer) at −20 °C until pro-
cessing for immunohistochemistry [16]. For the detec-
tion of BrdU-positive cells in brain sections, DNA
denaturation was performed prior to incubation with
anti-BrdU antibody as follows: incubation in 50 % form-
amide/2× SSC (0.3 M NaCl, 0.03 M sodium citrate) for
2 h at 65 °C, rinsing in 2× SSC for 5 min, incubation in
2 N HCl for 30 min at 37 °C, and rinsing in 0.1 M boric
acid (pH 8.5) for 10 min at room temperature. Floating
brain sections were incubated in 0.3 % H2O2 solution for
10 min, and rinsed with 0.1 % Triton X-100 in TBS
(TBST). Brain sections were incubated with blocking
buffer containing 3 % BSA and goat antiserum to mouse
IgG (1:50; Cappel Laboratories, PA, USA) in TBST for
30 min. After thorough washing, the sections were reacted
with mouse anti-BrdU monoclonal antibody (1:500:
Roche, Basel, Switzerland), overnight at 4 °C. After further
washing, the sections were incubated with secondary anti-
body, biotin-conjugated secondary antibody (1:500; goat
polyclonal anti-mouse IgG, Invitrogen) for 2 h, and subse-
quently treated with avidin-biotin peroxidase solution
(ABC kit, Vectastain Vector, USA) for 1 h at room
temperature. BrdU-positive cells were visualized by incu-
bation with a solution containing 0.02 % 3,3′-diaminoben-
zidine tetrahydrochloride (DAB) (Dojindo, Kumamoto,
Japan) and 0.005 % H2O2 (Wako, Japan) in 0.05 M Tris–
HCl buffer (pH 7.6), 1 % cobalt chloride (CoCl2) and 1 %
nickel sulphate (NiSO4) solution until brown reaction
products appeared. The brain sections were dehydrated
through a series of ethanol solutions and xylene, and
cover-slipped with Permount® (Fisher Scientific, Waltham,
MA, USA).
BrdU-immunopositive cells in the olfactory bulb (OLF),
rostral migratory stream (RMS), subventricular zone
(SVZ), and subgranular zone (SGZ) were counted in every
eighth section in a series of 30 μm brain sections using
Image J software. The total number of BrdU-positive cells
was estimated by multiplying the result by eight.
For the analysis of immature neuronal positioning, brain
sections were incubated with guinea pig anti-doublecortin
(DCX) polyclonal antibody (1:1000; Millipore, Billerica,
MA, USA) overnight at 4 °C. After washing, the brain sec-
tions were labelled with second antibody, Alexa Fluor
594-conjugated anti-guinea pig IgG (1:1000), for 2 h at
room temperature. Localization patterns of cells were
evaluated using a previously described method with slight
modifications [74]. Images of DCX-positive neurons with
Hoechst 33342 staining were used to determine cell
localization.
Drug treatments
Atomoxetine hydrochloride was purchased as Strattera®
Capsules from Eli Lilly, Indianapolis, IN, USA. The tablets
were crushed and resuspended in physiological saline, and
used for intraperitoneal administration (i.p.) at a dose of
1 mg/kg. D-cycloserine (Wako Chemical, Japan), a select-
ive partial agonist of the NMDA receptor glycine recogni-
tion site, was dissolved in physiological saline, and used at
20 mg/kg (i.p.). Nefiracetam (N-[2,6-Dimethylphenyl]-2-
[2-oxo-1-pyrrolidinyl]acetamide), a pyrrolidone derivative
nootropic drug, which potentiates neural activity via an
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interaction with the NMDA receptor glycine recognition
site, was kindly provided by Daiichi Pharmaceutical Co.,
Ltd. (Tokyo, Japan). Before administration, nefiracetam
was dissolved in physiological saline, and used at 1 mg/
kg (i.p.). Saline was used for control (vehicle) injections.
Atomoxetine, D-cycloserine, and nefiracetam were ad-
ministered once a day for seven consecutive days and
behavioral tests were performed 24 h after the last
administration.
Statistical analysis
Statistical analyses were done by one-way analysis of
variance (ANOVA) with the Tukey’s multiple compari-
son post-hoc test, two-way repeated measures ANOVA,
Student’s t test or Kaplan–Meier survival plots and log-
rank test using Graph Pad Prism 6 software. All results
are expressed as means ± standard error of the mean
(s.e.m.).
Additional file
Additional file 1: Figure S1. In Gng7wt/cre and Hbegfflox/flox mice, used
for mating to generate Hbegf cKO mice, lacZ positive cells were not
observed in the dentate gyrus. (TIF 9882 kb)
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